AutoGenomics competitors

K Newton are a Board Member at MIMEDX GROUP, INC.; Senior VP/CFO/COO at ARTHROCARE CORPORATION; and Chief Executive Officer at APOLLO ENDOSURGERY, INC.. They have worked as President/CEO at Synenco Energy Inc, Exec VP/CFO at Synenco Energy Inc, and Board Member at Synenco Energy Inc. K work or have worked as MEMBER at Minnesota State Society of CPAs, MEMBER at Texas State Society of Certified Public Accountants, and MEMBER at American Inst of Certified Public Accountants. They studied at UTSA - The University of Texas at San Antonio.

Dr. Singh was elected President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and appointed to our board of directors in August 2019. Previously Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals. Dr. Singh has more than twenty-five years of leadership experience with global innovators in healthcare technology. He has spent the most recent six years developing unique insights into both our business and our opportunities for continued growth. Dr. Singh brings to our board a detailed understanding of the core technologies that we utilize and the operational strategies available to us as we continue to focus on innovating for a healthier world.

Founder of The Chopra Foundation, a non-profit entity for research on well-being and humanitarianism, and Chopra Global, a whole health company at the intersection of science and spirituality, is a world-renowned pioneer in integrative medicine and personal transformation. Chopra is a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego and serves as a senior scientist with Gallup Organization.

After receiving his BS in organic chemistry from Colorado State, Dr. Maxey worked as a medicinal chemist at the Upjohn Company in Kalamazoo, Michigan. He entered medical school at the University of Michigan in 1980, and after graduation, dedicated his full attention to Cayman Chemical, a research biochemical company he started while still a medical student. Dr. Maxey has been a consultant and expert witness for multiple pharmaceutical companies, as well as a contributing editor and reviewer for Prostaglandins and Lipid Mediators.